The data looked at underlying health conditions, including diabetes and heart conditions.
Even with case counts and death tolls climbing across the US, many Americans have clung to the hope that, if they contracted the coronavirus, the illness would pass quickly or even asymptomatically. A new study released today by the Centers For Disease Control and Prevention, however, shows that a large percentage of the US may beReferring to self-reported data from the 2018 Behavioral Risk Factor Surveillance System and US Census population data, the CDC found that 40.
The data is sourced from 437,500 adults across every county in the US, so the researchers were able to identify broader patterns by region. They noted that while the estimated number of people with underlying conditions was higher in"population-dense metropolitan areas," the conditions were more commonly found in rural nonmetropolitan areas.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Coronavirus updates: CDC changes guidance on isolating adults with COVID-19Pres. Trump says there are 'likely a number of causes for the spike in infections,' including 'substantial increase of travel' and 'increased gathering on holidays such as Memorial Day, as well as young people closely congregating at bars.'
Read more »
Biden, Obama reunite for socially distanced conversation, slam Trump’s handling of COVID-19 crisisTheir talk will be streamed Thursday on their social media channels.
Read more »
U.S. to pay Pfizer, BioNTech $1.95 billion for millions of COVID-19 vaccine dosesPfizer Inc and German biotech firm BioNTech SE will get $1.95 billion from the U.S. government to produce and deliver 100 million doses of their COVID-19 vaccine candidate, the companies said on Wednesday.
Read more »
US government and Pfizer reach deal to produce millions of Covid-19 vaccine dosesThe US announces an agreement with Pfizer for the delivery of 100 million doses of a Covid-19 vaccine. The drugmaker still needs to complete a large Phase 3 clinical trial.
Read more »
US signs contract with Pfizer for COVID-19 vaccine dosesHealth and Human Services Secretary Alex Azar says the U.S. signed a contract with Pfizer for delivery in December of the first 100 million doses of a COVID-19 vaccine the pharmaceutical company is working to develop.
Read more »